In Vitro Antichemotactic Activity of Chamomilla recutita Hydroethanol Extract

References

• Avallone R, Zanoli P, Corsil L, Cannazza G, Baraldi M (1996): Benzodiazepine-like compounds and GABA in flower head of Matricaria chamomilla.. Phytotherapy Res 10: S177–S179.
   Google Scholar
• Avallone R, Zanoli P, Puia G, Kleinschnitz M, Schreier P, Baraldi M (2000): Pharmacological profile of apigenin, a flavonoid isolated from Matricaria chamomilla.. Biochem Pharmacol 59: 1387–1394.
   PubMed Web of Science ®Google Scholar
• Baggiolini M (1998): Chemokines and leukocyte traffic. Nature 392: 565–568.
   PubMed Web of Science ®Google Scholar
• Beretz A, Anton R, Stoclet JC (1978): Flavonoid compounds are potent inhibitors of cyclic AMP phosphodiesterase. Experientia 34: 1054–1055.
   PubMedGoogle Scholar
• Birt DF, Mitchell D, Gold B, Pour P, Pinch HC (1997): Inhibition of ultraviolet light induced skin carcinogenesis in SKH-1 mice by apigenin, a plant flavonoid. Anticancer Res 17: 85–91.
   PubMed Web of Science ®Google Scholar
• Blumenthal M (2000): The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin, TX, Integrative Medicine Communications.
   Google Scholar
• Boyden S (1962): The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med 115: 453–466.
   PubMed Web of Science ®Google Scholar
• Brantl V (1984): Novel opioid peptides derived from β.-casein: Human β.-casomorphins. Eur J Pharmacol 106: 213–214.
   PubMedGoogle Scholar
• Brantl V, Teschemacher H, Blasig J, Henschen A, Lottspeich F (1981): Opioid activities of β.-casomorphins. Life Sci 28: 1903–1909.
   PubMed Web of Science ®Google Scholar
• Brown DJ, Dattner AM (1998): Phytotherapeutic approaches to common dermatologic condition. Arch Dermatol 134: 1401–1404.
   PubMedGoogle Scholar
• Buratti T, Schratzberger P, Dunzendorfer S, Manfreda SE, Pechlaner C, Joannidis M, Sacerdote P, Panerai AE, Wiedermann CJ (1998): Decreased levels of β.-endorphin in circulating mononuclear leukocytes from patients with acute myocardial infarction.Cardiology 90: 43–47.
   PubMed Web of Science ®Google Scholar
• Caldiroli E, Leoni O, Cattaneo S, Rasini E, Marino V, Tosetto C, Mazzone A, Fietta AM, Lecchini S, Frigo GM (1999): Neutrophil function and opioid receptor expression on leucocytes during chronic naltrexone treatment in humans. Pharmacol Res 40: 153–158.
   PubMedGoogle Scholar
• Cauffield JS, Forbes HJ (1999): Dietary supplements used in the treatment of depression, anxiety, and sleep disorders. Lippincotts Prim Care Practice 3: 290–304.
   PubMedGoogle Scholar
• Charlin V, Defilippi C, Vargas V, Borghesi L, Gomez E (1992): Treatment of acute secretory diarrhea with casein: An effect of β.-casomorphins? Rev Med Chilena 120: 666–669.
   PubMed Web of Science ®Google Scholar
• Chuang TK, Killam KF Jr., Chuang LF, Kung HF, Sheng WS, Chao CC, Yu L, Chuang RY (1995): Mu opioid receptor gene expression in immune cells. Biochem Biophys Res Commun 216: 922–930.
   PubMed Web of Science ®Google Scholar
• Claustre J, Toumi F, Trompette A, Jourdan G, Guignard H, Chayvialle JA, Plaisancie P (2002): Effects of peptides derived from dietary proteins on mucus secretion in rat jejunum. Am J Physiol Gastrointest Liver Physiol 283: G521–G528.
   PubMed Web of Science ®Google Scholar
• De la Motte S, Bose-O'Reilly S, Heinisch M, Harrison F (1997): Double-blind comparison of an apple pectin-chamomile extract preparation with placebo in children with diarrhea. Arzneimittelforschung 47: 1247–1249.
   PubMedGoogle Scholar
• Defilippi C, Gomez E (1995): Effect of casein and casein hydrolysate on small bowel motility and d-xylose absorption in dogs. Neurogastroenterol Motil 7: 229–234.
   PubMed Web of Science ®Google Scholar
• Defilippi C, Gomez E, Charlin V, Silva C (1995): Inhibition of small intestinal motility by casein: A role of β.-casomorphins? Nutrition 11: 751–754.
   PubMed Web of Science ®Google Scholar
• Falke NE, Fischer EG, Martin R (1985): Stereospecific opiate binding in living human polymorphonuclear leucocytes. Cell Biol Int Rep 9: 1041–1047.
   PubMedGoogle Scholar
• Fidler P, Loprinzi CL, O'Fallon JR (1996): Prospective evaluation of a chamomile mouthwash for prevention of 5-FU-induced oral mucositis. Cancer 77: 522–525.
   PubMed Web of Science ®Google Scholar
• Gerritsen ME, Carley WW, Ranges GE, Shen CP, Phan SA, Ligon GF, Perry CA (1995): Flavonoids inhibit cytokine-induced endothelial cell adhesion protein gene expression. Am J Pathol 147: 278–292.
   PubMed Web of Science ®Google Scholar
• Gomaa A, Hashem T, Mohamed M, Ashry E (2003): Matricaria chamomilla. extract inhibits both development of morphine dependence and expression of abstinence syndrome in rats. J Pharmacol Sci 92: 50–55.
   PubMedGoogle Scholar
• Grimm MC, Ben-Baruch A, Taub DD, Howard OM, Resau JH, Wang JM, Ali H, Richardson R, Snyderman R, Oppenheim JJ (1998a): Opiates transdeactivate chemokine receptors: delta and mu opiate receptor-mediated heterologous desensitization. J Exp Med 188: 317–325.
   PubMed Web of Science ®Google Scholar
• Grimm MC, Ben-Baruch A, Taub DD, Howard OM, Wang JM, Oppenheim JJ (1998b): Opiate inhibition of chemokine-induced chemotaxis. Ann N Y Acad Sci 840: 9–20.
   PubMedGoogle Scholar
• Hernandez-Ceruelos A, Madrigal-Bujaidar E, De la Cruz C (2002): Inhibitory effect of chamomile essential oil on the sister chromatid exchanges induced by daunorubicin and methyl methanesulfonate in mouse bone marrow. Toxicol Lett 135: 103–110.
   PubMedGoogle Scholar
• Hofbauer R, Frass M, Gmeiner B, Kaye AD, Frost EA (2000): Garlic extract (Allium sativum.) reduces migration of neutrophils through endothelial cell monolayers. Middle East J Anesthesiol 15: 649–658.
   PubMedGoogle Scholar
• Hofbauer R, Frass M, Gmeiner B, Kaye AD, Frost EA (2001): Effects of garlic extract (Allium sativum). on neutrophil migration at the cellular level. Heart Dis 3, 14–17.
   PubMedGoogle Scholar
• Isaac O (1979): Pharmacological investigations with compounds of chamomile on the pharmacology of (−)-α.-bisabolol and bisabolol oxides (review). Planta Med 35: 118–124.
   PubMedGoogle Scholar
• Jakovlev V, Isaac O, Thiemer K, Kunde R (1979): Pharmacological investigations with compounds of chamomile. II. New investigations on the antiphlogistic effects of (−)-α.-bisabolol and bisabolol oxides. Planta Med 35: 125–140.
   PubMed Web of Science ®Google Scholar
• Jakovlev V, Isaac O, Flaskamp E (1983): Pharmacologic studies on chamomile compounds. VI. Studies on the antiphlogistic effect of chamazulene and matricine. Planta Med 49: 67–73.
   PubMed Web of Science ®Google Scholar
• Kaczor A, Matosiuk D (2002a): Non-peptide opioid receptor ligands—recent advances. Part I—agonists. Curr Med Chem 9: 1567–1589.
   PubMed Web of Science ®Google Scholar
• Kaczor A, Matosiuk D (2002b): Non-peptide opioid receptor ligands—recent advances. Part II—antagonists. Curr Med Chem 9: 1591–1603.
   PubMed Web of Science ®Google Scholar
• Larzelere MM, Wiseman P (2002): Anxiety, depression, and insomnia. Prim Care 29: 339–360.
   PubMed Web of Science ®Google Scholar
• Lepley DM, Li B, Birt DF, Pelling JC (1996): The chemopreventive flavonoid apigenin induces G2/M arrest in keratinocytes. Carcinogenesis 17: 2367–2375.
   PubMed Web of Science ®Google Scholar
• Leung AY, Foster S (1998): In: Encyclopedia of Common Natural Ingredients. New York, Wiley-Interscience, p. 164A.
   Google Scholar
• Lewis SL, Van Epps DE (1983): Demonstration of specific receptors for fluoresceinated casein on human neutrophils and monocytes using flow cytometry. Inflammation 7: 363–375.
   PubMedGoogle Scholar
• Li B, Pinch H, Birt DF (1996): Influence of vehicle, distant topical delivery, and biotransformation on the chemopreventive activity of apigenin, a plant flavonoid, in mouse skin. Pharm Res 13: 1530–1534.
   PubMed Web of Science ®Google Scholar
• Liang YC, Huang YT, Tsai SH, Lin-Shiau SY, Chen CF, Lin JK (1999): Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis 20: 1945–1952.
   PubMed Web of Science ®Google Scholar
• Liu Y, Blackbourn DJ, Chuang LF, Killam Jr KF, Chuang RY (1992): Effects of in vivo. and in vitro. administration of morphine sulfate upon rhesus macaque polymorphonuclear cell phagocytosis and chemotaxis. J Pharmacol Exp Ther 263: 533–539.
   PubMed Web of Science ®Google Scholar
• Lomas DA, Ip M, Chamba A, Stockley RA (1991): The effect of in vitro. and in vivo. dexamethasone on human neutrophil function. Agents Actions 33: 279–285.
   PubMedGoogle Scholar
• Madisch A, Melderis H, Mayr G, Sassin I, Hotz J (2001): A plant extract and its modified preparation in functional dyspepsia. Results of a double-blind placebo controlled comparative study. Zeitschrift fur Gastroenterologie 39: 511–517.
   PubMed Web of Science ®Google Scholar
• Madrid AM, Gomez E, Defilippi C (1996): Effects of casein on small intestine motility in patients with liver cirrhosis. Rev Med Chile 124: 171–177.
   PubMedGoogle Scholar
• Maiche AG, Grohn P, Maki-Hokkonen H (1991) Effect of chamomile cream and almond ointment on acute radiation skin reaction. Acta Oncol 30: 395–396.
   PubMed Web of Science ®Google Scholar
• Makman MH (1994): Morphine receptors in immunocytes and neurons. Adv Neuroimmunol 4: 69–82.
   PubMedGoogle Scholar
• Makman MH, Bilfinger TV, Stefano GB (1995): Human granulocytes contain an opiate alkaloid-selective receptor mediating inhibition of cytokine-induced activation and chemotaxis. J Immunol 154: 1323–1330.
   PubMed Web of Science ®Google Scholar
• Mann C, Staba EJ (1986): The chemistry, pharmacology, and commercial formulations of chamomile. In: Craker LE, Simon JE, eds., Herbs, Spices and Medicinal Plants: Recent Advances in Botany, Horticulture, and Pharmacology, Vol. 1. Phoenix, Arizona, Oryx Press, pp. 235–280.
   Google Scholar
• Marcoli M, Ricevuti G, Mazzone A, Bekkering M, Lecchini S, Frigo GM (1988): Opioid-induced modification of granulocyte function. Int J Immunopharmacol 10: 425–433.
   PubMed Web of Science ®Google Scholar
• Mazzone A, Fossati G, Mazzucchelli I, Gritti D, Canale C, Ricevuti G (1996): Opioid receptor and phagocyte defects in drug addicts. Recent Prog Med 87: 530–537.
   PubMedGoogle Scholar
• McCarthy L, Wetzel M, Sliker JK, Eisenstein TK, Rogers TJ (2001): Opioids, opioid receptors, and the immune response. Drug Alcohol Depend 62: 111–123.
   PubMed Web of Science ®Google Scholar
• Miller T, Wittstock U, Lindequist U, Teuscher E (1996): Effects of some components of the essential oil of chamomile, Chamomilla recutita., on histamine release from rat mast cells. Planta Med 62: 60–61.
   PubMedGoogle Scholar
• Mills S, Bone K (2000): Principles and Practice of Phytotherapy—Modern Herbal Medicine. Edinburgh, Churchill Livingstone, p. 643.
   Google Scholar
• Mori S, Goto K, Goto F, Murakami K, Ohkawara S, Yoshinaga M (1994): Dynamic changes in mRNA expression of neutrophils during the course of acute inflammation in rabbits. Int Immunol 6: 149–156.
   PubMedGoogle Scholar
• Muller AA, Reiter SA, Heider KG, Wagner H (1999): Plan-derived acetophenones with antiasthmatic and antiinflammatory properties: Inhibitory effects in chemotaxis, right angle scatter and actin polimerization of polymorphonucleare granulocytes. Planta Med 65: 590–594.
   PubMed Web of Science ®Google Scholar
• Pasotti D, Mazzone A, Ricevuti G (1992): The nervous system and the immune system: The role of morphine and opioid peptides in the function of neutrophilic granulocytes. Minerva Med 83: 433–438.
   PubMedGoogle Scholar
• Perez-Castrillon JL, Perez-Arellano JL, Garcia-Palomo JD, Jimenez-Lopez A, De Castro S (1992): Opioids depress in vitro. human monocyte chemotaxis. Immunopharmacology 23: 57–61.
   PubMedGoogle Scholar
• Picq M, Dubois M, Prigent AF, Nemoz G, Pacheco H (1989): Inhibition of the different cyclic nucleotide phosphodiesterase isoforms separated from rat brain by flavonoid compounds. Biochem Int 18: 47–57.
   PubMedGoogle Scholar
• Rekka EA, Kourounakis AP. Kourounakis PN (1996): Investigation of the effect of chamazulene on lipid peroxidation and free radical processes. Res Commun Mol Pathol Pharmacol 92: 361–364.
   PubMed Web of Science ®Google Scholar
• Safayhi H, Sabieraj J, Sailer ER, Ammon HP (1994): Chamazulene: An antioxidant-type inhibitor of leukotriene B4 formation. Planta Med 60: 410–413.
   PubMed Web of Science ®Google Scholar
• Scalia S, Giuffreda L, Pallado P (1999): Analytical and preparative supercritical fluid extraction of chamomile flowers and its comparison with conventional methods. J Pharm Biomed Anal 21: 549–558.
   PubMed Web of Science ®Google Scholar
• Sharp BM (2003): Opioid receptor expression and intracellular signaling by cells involved in host defense and immunity. Adv Exp Med Biol 521: 98–105.
   PubMed Web of Science ®Google Scholar
• Shen Y-C, Chou C-J, Chiou W-F, Chen C-F (2001): Anti-inflamatory effects of the partially purified extract of radix Stephaniae tetrandrae. comparative studies of its active principles tetrandrine and fangchinoline on human polymorphonuclear leukocyte functions. Mol Pharmacol 60: 1083–1090.
   PubMed Web of Science ®Google Scholar
• Siddiqui RA, Akard LP, Garcia JG, Cui Y, English D (1999): Chemotactic migration triggers IL-8 generation in neutrophilic leukocytes. J Immunol 162: 1077–1083.
   PubMedGoogle Scholar
• Simpkins CO, Alailima ST, Tate EA (1986): Inhibition by naloxone of neutrophil superoxide release: a potentially useful antiinflammatory effect. Circulation Shock 20: 181–191.
   PubMedGoogle Scholar
• Szabo I, Rogers TJ (2001): Crosstalk between chemokine and opioid receptors results in downmodulation of cell migration. Adv Exp Med Biol 493: 75–79.
   PubMed Web of Science ®Google Scholar
• Szabo I, Chen XH, Xin L, Adler MW, Howard OM, Oppenheim JJ, Rogers TJ (2002): Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain. Proc Natl Acad Sci USA 99: 10276–10281.
   PubMed Web of Science ®Google Scholar
• Tubaro A, Zilli C, Redaelli C, Della Loggia R (1984): Evaluation of antiinflammatory activity of a chamomile extract topical application. Planta Med 50: 359.
   Web of Science ®Google Scholar
• Viola H, Wasowski C, Levi de Stein M, Wolfman C, Silveira R, Dajas F, Medina JH, Paladini AC (1995): Apigenin, a component of Matricaria recutita. flowers, is a central benzodiazepine receptors-ligand with anxiolytic effects. Planta Med 61: 213–216.
   PubMed Web of Science ®Google Scholar
• Weizman Z, Alkrinawi S, Goldfarb D, Bitran C (1993): Efficacy of herbal tea preparation in infantile colic. J Pediatr 122: 650–652.
   PubMedGoogle Scholar
• Zentay Z, Sharaf M, Qadir M, Drafta D, Davidson D (1999): Mechanism for dexamethasone inibition of neutrophil migration upon exposure to lipopolysaccharide in vitro.: Role of neutrophil interleukin-8 release. Pediatr Res 46: 406–410.
   PubMedGoogle Scholar